Volume 66, Issue 1, Pages (July 2014)

Slides:



Advertisements
Similar presentations
Volume 68, Issue 6, Pages (December 2015)
Advertisements

Volume 50, Issue 3, Pages (September 2006)
Clinical Prediction Model To Characterize Pulmonary Nodules
Volume 62, Issue 4, Pages (October 2012)
European Urology Focus
Global Trends in Testicular Cancer Incidence and Mortality
Volume 58, Issue 1, Pages (July 2010)
Epidemiology and Risk Factors of Urothelial Bladder Cancer
Volume 67, Issue 5, Pages (May 2015)
Volume 49, Issue 2, Pages (February 2006)
Volume 61, Issue 5, Pages (May 2012)
Volume 51, Issue 6, Pages (June 2007)
Volume 63, Issue 4, Pages (April 2013)
Volume 70, Issue 6, Pages (December 2016)
Volume 51, Issue 3, Pages (March 2007)
Histologic Grading of Noninvasive Papillary Urothelial Neoplasms
Volume 53, Issue 5, Pages (May 2008)
Volume 71, Issue 6, Pages e171-e172 (June 2017)
Volume 61, Issue 4, Pages (April 2012)
Volume 63, Issue 6, Pages (June 2013)
Volume 56, Issue 3, Pages (September 2009)
Volume 63, Issue 4, Pages (April 2013)
Volume 67, Issue 4, Pages (April 2015)
Volume 59, Issue 2, Pages (February 2011)
Volume 63, Issue 1, Pages (January 2013)
Volume 63, Issue 4, Pages e53-e56 (April 2013)
Volume 66, Issue 2, Pages (August 2014)
The Global Risk of Bladder Cancer: Let's Just Do Something About It!
Nomograms for Bladder Cancer
Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 51, Issue 5, Pages (May 2007)
Volume 73, Issue 2, Pages (February 2018)
Volume 61, Issue 5, Pages (May 2012)
Volume 52, Issue 5, Pages (November 2007)
Volume 60, Issue 5, Pages (November 2011)
Volume 53, Issue 4, Pages (April 2008)
Volume 68, Issue 1, Pages (July 2015)
Volume 71, Issue 5, Pages (May 2017)
Volume 69, Issue 3, Pages (March 2016)
Volume 64, Issue 3, Pages (September 2013)
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Stephen B. Williams, Ashish M
Volume 66, Issue 6, Pages (December 2014)
Volume 54, Issue 3, Pages (September 2008)
Volume 67, Issue 6, Pages (June 2015)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Volume 62, Issue 2, Pages (August 2012)
Volume 59, Issue 1, Pages (January 2011)
Volume 60, Issue 6, Pages (December 2011)
European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update
Volume 56, Issue 5, Pages (November 2009)
The Economic Costs of Overactive Bladder in Germany
Volume 53, Issue 1, Pages (January 2008)
Volume 69, Issue 6, Pages (June 2016)
Volume 50, Issue 5, Pages (November 2006)
Volume 73, Issue 1, Pages (January 2018)
Prostate Cancer Nomograms: An Update
Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA  Nawar Hanna, Quoc-Dien Trinh,
Testicular Cancer Variations in Time and Space in Europe
Volume 49, Issue 4, Pages (April 2006)
Volume 55, Issue 6, Pages (June 2009)
Georges-Pascal Haber, Sebastien Crouzet, Inderbir S. Gill 
Volume 52, Issue 1, Pages (July 2007)
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Maximilian Burger, Ashish M. Kamat, David McConkey 
How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James.
Presentation transcript:

Volume 66, Issue 1, Pages 156-163 (July 2014) Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort  Atiqullah Aziz, Matthias May, Maximilian Burger, Rein-Jüri Palisaar, Quoc-Dien Trinh, Hans-Martin Fritsche, Michael Rink, Felix Chun, Thomas Martini, Christian Bolenz, Roman Mayr, Armin Pycha, Philipp Nuhn, Christian Stief, Vladimir Novotny, Manfred Wirth, Christian Seitz, Joachim Noldus, Christian Gilfrich, Shahrokh F. Shariat, Sabine Brookman-May, Patrick J. Bastian, Stefan Denzinger, Michael Gierth, Florian Roghmann  European Urology  Volume 66, Issue 1, Pages 156-163 (July 2014) DOI: 10.1016/j.eururo.2013.12.018 Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 1 Calibration plot of the Isbarn nomogram predicting 90-d mortality after radical cystectomy in the present cohort. Variables included age (≤60 vs 61–68, 69–83, 84–88, ≥89 yr), stage (regional vs localized), grade (1–2 vs 3–4), and histologic subtype (urothelial carcinoma vs squamous cell carcinoma, other). Abbreviations: Dxy=Somer's D rank correlation, R2=Nagelkerke-Cox-Snell-Maddala-Magee R-squared index, D=Discrimination index, U=Unreliability index, Q=Quality index, Emax=maximum absolute difference in predicted and calibrated propabilities, S:z=Spiegelhalter Z-test, S:p=two-tailed p-value of the Spiegelhalter Z-test. European Urology 2014 66, 156-163DOI: (10.1016/j.eururo.2013.12.018) Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 2 Calibration plot of the newly developed preoperative nomogram predicting 90-d mortality after radical cystectomy. Abbreviations: Dxy=Somer's D rank correlation, R2=Nagelkerke-Cox-Snell-Maddala-Magee R-squared index, D=Discrimination index, U=Unreliability index, Q=Quality index, Emax=maximum absolute difference in predicted and calibrated propabilities, S:z=Spiegelhalter Z-Test, S:p=two-tailed p-value of the Spiegelhalter Z-test. European Urology 2014 66, 156-163DOI: (10.1016/j.eururo.2013.12.018) Copyright © 2013 European Association of Urology Terms and Conditions

Fig. 3 Preoperative nomogram predicting 90-d mortality after radical cystectomy. To obtain the nomogram-predicted probability of 90-d mortality, locate the patient values on each axis. Draw a vertical line to the “Points” axis to determine how many points are attributed for each variable value. Add the points of all variables. Locate the sum on the “Total Points” line to assess the individual probability of 90-d mortality. ASA=American Society of Anesthesiologists. European Urology 2014 66, 156-163DOI: (10.1016/j.eururo.2013.12.018) Copyright © 2013 European Association of Urology Terms and Conditions